Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
Follow-Up Questions
Who is the CEO of ACRO Biomedical Co Ltd?
Mr. Pao-Chi Chu is the President of ACRO Biomedical Co Ltd, joining the firm since 2017.
What is the price performance of ACBM stock?
The current price of ACBM is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for ACRO Biomedical Co Ltd?
ACRO Biomedical Co Ltd belongs to Health Care industry and the sector is Health Care
